We are live on
!
Find out more
PRTG
Post Resch Tallon Group Portfolio holdings
AUM
$145M
1-Year Est. Return
25.19%
This Fund
S&P 500
This Quarter
Est. Return
-2.03%
1 Year Est. Return
+25.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$98M
AUM Growth
-$5.92M
(-5.7%)
Cap. Flow
+$191K
Cap. Flow
% of AUM
0.19%
Top 10 Holdings %
Top 10 Hldgs %
45.89%
Holding
109
New
3
Increased
30
Reduced
45
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$529K |
| 2 |
iShares Russell 3000 ETF
IWV
|
+$317K |
| 3 |
Codexis
CDXS
|
+$252K |
| 4 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$213K |
| 5 |
iShares Core US REIT ETF
USRT
|
+$208K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Paychex
PAYX
|
+$1.47M |
| 2 |
Xylem
XYL
|
+$260K |
| 3 |
Salesforce
CRM
|
+$236K |
| 4 |
TSMC
TSM
|
+$228K |
| 5 |
KKR & Co
KKR
|
+$207K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.03% |
| 2 | Real Estate | 7.05% |
| 3 | Healthcare | 6.29% |
| 4 | Financials | 4.56% |
| 5 | Communication Services | 2.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Sharplink Inc
SBET
$1.29B
| $13.8K | 0.01% |
3,555
| – | – |
|
|
ZOM
102
DELISTED
Zomedica Corp.
ZOM
| $8.85K | 0.01% |
150,000
| – | – |
|
103
Chord Energy
CHRD
$7.68B
| – | – |
-1,717
| Closed | -$204K |
|
|
104
Salesforce
CRM
$154B
| – | – |
-714
| Closed | -$236K |
|
105
CALL
Digimarc Corp
DMRC
$143M
| – | – |
-1,300
| Closed | -$20.1K |
|
|
106
KKR & Co
KKR
$89.1B
| – | – |
-1,386
| Closed | -$207K |
|
|
107
TSMC
TSM
$1.94T
| – | – |
-1,130
| Closed | -$228K |
|
|
108
Xylem
XYL
$28.5B
| – | – |
-2,241
| Closed | -$260K |
|
Similar funds
FC
CGF
I
CFP
KK
C
MCM
ACM
Post Resch Tallon Group's Q1 2025 Portfolio in Review
As of Q1 2025, Post Resch Tallon Group held 109 positions worth $98M, down 5.7% from $104M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Post Resch Tallon Group's Q1 2025 filing shows 3 new, 30 increased, 45 reduced and 7 closed positions. Its largest new stake was Bristol-Myers Squibb: 3,466 shares worth $206K. The largest sale was Paychex, an estimated $1.47M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 16% a quarter earlier, followed by Real Estate and Healthcare.
- Post Resch Tallon Group's largest Q1 2025 buy was Bristol-Myers Squibb: 3,466 shares worth $206K.
- Post Resch Tallon Group added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $529K increase.
- Post Resch Tallon Group's biggest Q1 2025 reduction was Paychex, cutting an estimated $1.47M.
- Post Resch Tallon Group fully exited Xylem in Q1 2025, selling an estimated $260K.
- Post Resch Tallon Group's ten largest holdings make up 46% of its $98M portfolio in Q1 2025.
- Post Resch Tallon Group opened 3 new positions and closed 7 in Q1 2025.
- Post Resch Tallon Group's portfolio value fell 5.7% quarter-over-quarter to $98M.
Based on Post Resch Tallon Group's 13F filing for Q1 2025, filed 23 Apr 2025.